Evaluation of Duloxetine for Chronic Pain Conditions

• Singh G , TriadafilopoulosG: Epidemiology of NSAID induced gastrointestinal complications.J. Rheumatol. Suppl.56 , 18–24 (1999).
   PubMedGoogle Scholar
• Paulozzi LJ , BudnitzDS, XiY: Increasing deaths from opioid analgesics in the United States.Pharmacoepidemiol. Drug Saf.15(9) , 618–627 (2006).
   PubMed Web of Science ®Google Scholar
• Skljarevski V , ZhangQ, DesaiahD et al.: Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial.J. Pain11(12) , 1282–1290 (2010).
   PubMed Web of Science ®Google Scholar
• Skljarevski V , DesaiahD, Liu-SeifertH et al.: Efficacy and safety of duloxetine in patients with chronic low back pain.Spine35(13) , E578–E585 (2010).
   PubMed Web of Science ®Google Scholar
• Chappell AS , OssannaMJ, Liu-SeifertH et al.: Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.Pain146(3) , 253–260 (2009).
   PubMed Web of Science ®Google Scholar
• Chappell AS , DesaiahD, Liu-SeifertH et al.: A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee.Pain Pract.11(1) , 33–41 (2010).
   Web of Science ®Google Scholar
• Whitmyer VG , DunnerDL, KornsteinSG et al.: A comparison of initial duloxetine dosing strategies in patients with major depressive disorder.J. Clin. Psychiatry68(12) , 1921–1930 (2007).
   PubMed Web of Science ®Google Scholar
• Wells KA , LosinWG: In vitro stability, potency, and dissolution of duloxetine enteric-coated pellets after exposure to applesauce, apple juice, and chocolate pudding.Clin. Ther.30(7) , 1300–1308 (2008).
   PubMed Web of Science ®Google Scholar
• Delgado PL , MillerHL, SalomonRM et al.: Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.Biol. Psychiatry46(2) , 212–220 (1999).
   PubMed Web of Science ®Google Scholar
• Millan MJ : Descending control of pain.Prog. Neurobiol.66(6) , 355–474 (2002).
   PubMed Web of Science ®Google Scholar
• Fields H : State-dependent opioids control of pain.Nat. Rev. Neurosci.5(7) , 565–575 (2004).
   PubMed Web of Science ®Google Scholar
• Coderre TJ , KatzJ: Peripheral and central hyperexcitability: differential signs and symptoms in persistent pain.Behav. Brain Sci.20(3) , 404–419 (1997).
   PubMed Web of Science ®Google Scholar
• Willis WD , WestlundKN: Neuroanatomy of the pain system and of the pathways that modulate pain.J. Clin. Neurophysiol.14(1) , 2–31 (1997).
   PubMed Web of Science ®Google Scholar
• Stahl SM : The psychopharmacology of painful physical symptoms in depression.J. Clin. Psychiatry63(5) , 382–383 (2002).
   PubMed Web of Science ®Google Scholar
• Fields HL , BasbaumAI: Textbook of Pain. Wall PD, Melzack R (Eds). Churchill Livingstone, London, UK, 309–312 (1999).
   Google Scholar
• Fishbain D : Evidence-based data on pain relief with antidepressants.Ann. Med.32(5) , 305–316 (2000).
   PubMed Web of Science ®Google Scholar
• Bymaster FP , Dreshfield-AhmadLJ, ThrelkeldPG et al.: Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.Neuropsychopharmacology25(6) , 871–880 (2001).
   PubMed Web of Science ®Google Scholar
• Bymaster FP , BeedleEE, FindlayJ et al.: Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.Bioorg. Med. Chem. Lett.13(24) , 4477–4480 (2003).
   PubMed Web of Science ®Google Scholar
• Bymaster FP , LeeTC, KnadlerMP, DetkeMJ, IyengarS: The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.Curr. Pharm. Des.11(12) , 1475–1493 (2005).
   PubMed Web of Science ®Google Scholar
• Lobo ED , QuinlanT, O‘BrienL, KnadlerMP, HeathmanM: Population pharmacokinetics of orally administered duloxetine in patients: Implications for dosing recommendations.Clin. Pharmacokinet.48(3) , 189–197 (2009).
   PubMed Web of Science ®Google Scholar
• Cymbalta ® package insert. Eli Lilly and Company, Indianapolis, IN, USA (2010).
   Google Scholar
• Suri A , ReddyS, GonzalesC, KnadlerMP, BranchRA, SkinnerMH: Duloxetine pharmacokinetics in cirrhotics compared with healthy subjects.Int. J. Clin. Pharmacol. Ther.43(2) , 78–84 (2005).
   PubMed Web of Science ®Google Scholar
• Lobo ED , HeathmanM, Kuan H-Y et al.: Effects of varying degrees of renal impairment on the pharmacokinetics of duloxetine: analysis of a single-dose Phase I study and pooled steady-state data from Phase II/III trials. Clin. Pharmacokinet.49(5) , 311–321 (2010).
   PubMed Web of Science ®Google Scholar
• Goldstein DJ , LuY, DetkeMJ, LeeTC, IyengarS: Duloxetine vs. placebo in patients with painful diabetic neuropathy.Pain116(1–2) , 109–118 (2005).
   PubMed Web of Science ®Google Scholar
• Raskin J , PritchettYL, WangF et al.: A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.Pain Med.6(5) , 346–356 (2005).
   PubMed Web of Science ®Google Scholar
• Wernicke JF , PritchettYL, D‘SouzaDN et al.: A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.Neurology67(8) , 1411–1420 (2006).
   PubMed Web of Science ®Google Scholar
• Guy W : ECDEU Assessment Manual for Psychopharmacology, Revised. US Department of Health, Education, and Welfare publication (ADM), National Institute of Mental Health, Rockville, MD, USA, 76–338 (1976).
   Google Scholar
• Cleeland CS , RyanKM: Pain assessment: global use of the Brief Pain Inventory.Ann. Acad. Med. Singapore23(2) , 129–138 (1994).
   PubMedGoogle Scholar
• Skljarevski V , DesaiahD, ZhangQ et al.: Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.Diabetes Metab. Res. Rev.25(7) , 623–631(2009).
   PubMed Web of Science ®Google Scholar
• Arnold LM , LuY, CroffordLJ et al.: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.Arthritis Rheum.50(9) , 2974–2984 (2004).
   PubMed Web of Science ®Google Scholar
• Arnold LM , RosenA, PritchettYL et al.: A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.Pain119(1–3) , 5–15 (2005).
   PubMed Web of Science ®Google Scholar
• Russell IJ , MeasePJ, SmithTR et al.: Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.Pain136(3) , 432–444 (2008).
   PubMed Web of Science ®Google Scholar
• Chappell AS , BradleyLA, WiltseC, DetkeMJ, D‘SouzaDN, SpaethM: A six-month double blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.Int. J. Gen. Med.1 , 91–102 (2008).
   PubMedGoogle Scholar
• Burckhardt CS , ClarkSR, BennettRM: The fibromyalgia impact questionnaire: development and validation.J. Rheumatol.18(5) , 728–733 (1991).
   PubMed Web of Science ®Google Scholar
• Arnold LM , ClauwDJ, WohlreichMM et al.: Efficacy of duloxetine in patients with fibromyalgia: pooled analysis of 4 placebo-controlled clinical trials.Prim. Care Companion J. Clin. Psychiatry11(5) , 237–244 (2009).
   PubMedGoogle Scholar
• Sheehan DV , Harnett-SheehanK, RajBA: The measurement of disability.Int. Clin. Psychopharmacol.11(Suppl 3) , 89–95 (1996).
   PubMed Web of Science ®Google Scholar
• Mease PJ , RussellIJ, KajdaszDK et al.: Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.Semin. Arthritis Rheum.39(6) , 454–464 (2010).
   PubMed Web of Science ®Google Scholar
• Choy EHS , MeasePJ, KajdaszDK et al.: Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials.Clin. Rheumatol.28(9) , 1035–1044 (2009).
   PubMed Web of Science ®Google Scholar
• Chappell AS , LittlejohnG, KajdaszDD, ScheinbergM, D‘SouzaDN, MoldofskyH: A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.Clin. J. Pain25(5) , 365–375 (2009).
   PubMed Web of Science ®Google Scholar
• Skljarevski V , OssannaM, Liu-SeifertH et al.: A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain.Eur. J. Neurol.16(9) , 1041–1048 (2009).
   PubMed Web of Science ®Google Scholar
• Roland M , MorrisR: A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain.Spine8(2) , 141–144 (1983).
   PubMed Web of Science ®Google Scholar
• Skljarevski V , ZhangS, ChappellAS, WalkerDJ, MurrayI, BackonjaM: Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.Pain Med.11(5) , 648–657 (2010).
   PubMed Web of Science ®Google Scholar
• Brunton S , WangF, EdwardsSB et al.: Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies.Drug Saf.33(5) , 393–407 (2010).
   PubMed Web of Science ®Google Scholar
• Lobo ED , BergstromRF, ReddyS et al.: In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine.Clin. Pharmacokinet.47(3) , 191–202 (2008).
   PubMed Web of Science ®Google Scholar
• Chappell J , HeJ, KnadlerMP et al.: Evaluation of the effect of duloxetine on the pharmacodynamics and pharmacokinetics of warfarin at steady-state in healthy subjects. Presented at: 37th Annual Meeting of American College of Clinical Pharmacology. Louisville, KY, USA, 18–22 October2008.
   Google Scholar
• Wasan AD , OssannaMJ, RaskinJ et al.: Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.Curr. Drug Saf.4(1) , 22–29 (2009).
   PubMedGoogle Scholar
• Raskin J , SmithTR, WongK et al.: Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.J. Palliat. Med.9(1) , 29–40 (2006).
   PubMed Web of Science ®Google Scholar
• Wernicke JF , RaskinJ, RosenA et al.: Duloxetine in the long-term management of diabetic peripheral neuropathic pain: an open-label, 52-week extension of a randomized, controlled clinical trial.Curr. Ther. Res.67(5) , 283–304 (2006).
   PubMed Web of Science ®Google Scholar
• Wernicke JF , WangF, PritchettYL et al.: An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.Pain Med.8(6) , 503–513 (2007).
   PubMed Web of Science ®Google Scholar
• March JS , EmslieGJ, KratochvilCJ et al.: An open-label study of tolerability, safety, and pharmacokinetics of duloxetine in children (7–11 years) and adolescents (12–17 years) with major depressive disorder. Presented at: 49th Annual Meeting of NCDEU. Hollywood, FL, USA, 29 June–2 July 2009.
   Google Scholar

▪ Websites

• American Pain Foundation: Chronic pain a problem for an estimated 50 to 90 million Americans www.beyondchronicpain.com/site/media/currentStatisticsOnChronicPain.php (Accessed 11August2010)
   Google Scholar
• National Center for Health Statistics Report: Health, United States, 2006, Special Feature on Pain www.cdc.gov/nchs/data/hus/hus06.pdf (Accessed 11August2010)
   Google Scholar
• Department of Health and Human Services, NIH: Mechanisms, Models, Measurement, and Management in Pain Research (R21) http://grants.nih.gov/grants/guide/pa-files/PA-10-007.html (Accessed 11August2010)
   Google Scholar
• American Pain Society: Pain assessment and treatment in the managed care environment. A position statement from the APS 2000 www.ampainsoc.org/advocacy/assess_treat_mce.htm (Accessed 11August2010)
   Google Scholar
• US FDA: Duloxetine for the management of chronic pain. FDA advisory committee on August 19 2010 Link (Accessed 28October2010)
   Google Scholar